News

TipRanks on MSN1d

Skye Bioscience Earnings Call: Positive Outlook Amid Challenges

Skye Bioscience, Inc. (($SKYE)) has held its Q2 earnings call. Read on for the main highlights of the call. Skye Bioscience’s recent earnings call ...

Skye Bioscience Reports Second Quarter 2025 Financial Results and Business Update

Detailed price information for Skye Bioscience Inc (SKYE-Q) from The Globe and Mail including charting and trades.

Skye Bioscience (SKYE) Gets a Buy from Piper Sandler

Detailed price information for Skye Bioscience Inc (SKYE-Q) from The Globe and Mail including charting and trades.

Skye Bioscience Inc (SKYE) Q2 2025 Earnings Call Highlights: Promising Trial Progress Amid ...

Skye Bioscience Inc (SKYE) reports significant advancements in clinical trials and financial stability, despite increased ...

Skye Bioscience signals late Q3/early Q4 top-line Phase IIa results as nimacimab advances obesity treatment platform

Q2 2025 Management View Punit S. Dhillon, President and CEO, highlighted the imminent reporting of Phase IIa data for ...